MarketInOut Stock Screener Log In | Sign Up

Sol-Gel Technologies Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Sol-Gel Technologies Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization223.25 mln
Float1.32 mln
Earnings Date11/05/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.57
Highly reliable

1-Year Forecast

152.50
Transformational upside

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.02
Debt-free

Pre-Tax Margin

-910%
Severely loss-making

Business Description

Founded in Israel in 1997, Sol-Gel Technologies develops prescription skin treatments for conditions such as acne, rosacea, and rare genetic skin disorders. The company already sells two approved creams ? Twyneo for acne and Epsolay for rosacea ? while advancing additional treatments through clinical trials. Sol-Gel works with partners including Padagis, Galderma, and Searchlight Pharma to bring its products to markets across North America, Europe, Asia, and beyond.

Key Fundamentals

EPS-5.61
ROE-45.32
RPS0.62
ROIC-203
ROA-37.80
EBITDA, mln-16.34
EV / EBITDA-11.98
EV / EBIT-11.98
Revenue, mln1.79
EV / Revenue109

Quote Details

Last 68.35
Change -0.31 (-0.45%)
Open 69.49
Volume 33,517
Turnover 2,290,887
Average Volume 38,714

Financial Ratios

Pre-Tax Profit Margin-910
Leverage Ratio1.12
Current Ratio10.37
Price / Book5.06
Price / Tangible Book5.06
Price / Free Cash Flow750
Debt / Equity0.02
Price / Sales121

Financial Strength

Altman Z-Score18.77
Piotroski F-Score 6 / 9
Beneish M-Score-3.57
1-Year Target Price152.50
Short Ratio2.55
Short % of Float13.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.58% 32 / 100   
1 Month -6.37% 36 / 100   
2 Months -14.38% 27 / 100   
6 Months -9.6% 36 / 100   
1 Year 84.73% 96 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog